Authors Posts by DealRoom Staff

DealRoom Staff

53 POSTS 0 COMMENTS

Recruiting for the most lucrative finance careers is incredibly competitive. Specifically, one of the most difficult positions to land is as an investment banking analyst. Firms typically only hire the most qualified undergraduates from the top undergraduate institutions in the world....

Here's our latest practice resource for aspiring bankers everywhere, and those who just want to test themselves and have some fun! Building on what was our most popular quiz so far, we're doing 10 more brain teaser questions pulled from investment...
Energy M&A in 2017

North America’s energy sector is witnessing increased interest from private equity firms, a decline in foreign buyers, and an IPO market in the midst of a rebound, according to Surging Ahead: Energy M&A in 2017, a new report prepared by Firmex...

The final and arguably toughest gateway into a lucrative finance career is the grueling interview process. It's a bit like passing the bar to become a lawyer, or defending your dissertation to get a Ph.D. After years of studying, it's time...

Note: The M&A fee survey is now closed. Stay tuned for the 2017 M&A Fee Guide with the survey results coming in September 2017. To make sure you receive the guide as soon as it is published, subscribe to The DealRoom newsletter.   Information about...

One of the most dreaded parts of any investment banking interview is the technical questions, when the person standing between you and your new, super well-paying job plumbs the depths of your financial modeling knowledge to see if you really know...

So you have a deal on the table, and now it's time to give it a name. On one hand, this is the fun part - you've spent all your time bringing parties to the table and you'll be neck deep...

As of May 1, there are 244 days left in 2017. If you’re involved in M&A, you may be wondering what the remainder of the year has in store for you and your business, and how busy you’ll be. Firmex surveyed...

In contrast to M&A levels in many other sectors, deal making activity in the pharmaceutical and biotechnology industries remained strong in 2016, but is this area likely to stay hot in 2017? In the latest edition of our quarterly report series, Firmex...

We wanted to understand how 2016 turned out for M&A professionals, we also wanted to understand how optimistic those in the industry were regarding the upcoming year. The M&A deal flow optimism in 2017 survey will poll industry professionals and report back findings...